approval · primary record
MIRVETUXIMAB SORAVTANSINE-GYNX
FDA · BLA · 2025-07-14
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-07-14 |
| Brand | ELAHERE |
| Sponsor | IMMUNOGEN INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:16.077Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:MIRVETUXIMAB SORAVTANSINE-GYNX:2025-07-14
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.